News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2025 Caitlin E. Cox April 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 Caitlin E. Cox April 01, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2022 Shelley Wood October 31, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2022 Shelley Wood October 03, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients Michael O'Riordan February 25, 2022
News Daily News ‘Nontrivial’ Amount of LA Thrombus Found Before AF Procedures Todd Neale June 08, 2021
News Daily News Nonstenotic Intracranial Plaque: An Underrecognized Source of Embolic Stroke Todd Neale February 10, 2021
News Conference News TCT 2020 Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19 Michael O'Riordan October 14, 2020
News Daily News Which Modality and When? New Guidance for Cardiac Imaging in COVID-19 Shelley Wood July 24, 2020
News Daily News Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves Michael O'Riordan May 27, 2020
News Conference News PCR London Valves 2019 TAVR in Bicuspid Aortic Valves: Insights From BIVOLUT-X Michael O'Riordan November 22, 2019
News Daily News Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis Caitlin E. Cox February 05, 2018
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017